Clinical Trials Browser

NCT01624220 2026-05-12

A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy

BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Melanoma, Neoplasms, Unknown Primary, Prostatic Neoplasms, Sarcoma, Spinal Cord Neoplasms, Thyroid Neoplasms

NCT05108298 2026-05-07

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Phase NA Recruiting

400 enrolled

BreastCNSDermatologicGastrointestinalGynecologicHead & NeckLymphoidOther hematologic neoplasmSarcoma

Bone Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Leukemia, Lymphoma, Melanoma, Sarcoma, Thyroid Neoplasms, Central Nervous System Neoplasms, Pyloric Stenosis, Hypertrophic

Clinical Trials

A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma

A Model for Genetic Susceptibility: Melanoma

EUNASS

BIOMIS-Onco

Melanoma Risk-Reduction Among Patients and Family Members

QUALM

Prospective Measurement of Post-Treatment Lymphedema

PennSCAPE

Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns

Symptom Burden in Patients With Cancer- and Treatment-Related Skin Problems

Tailored Intervention for Melanoma Patient's Families